Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The B-type acetylcholine receptor (AChR) in nematodes is a subtype of nicotinic acetylcholine receptors (nAChRs), which are pentameric ligand-gated ion channels mediating excitatory neurotransmission at the neuromuscular junctions of nematodes. These receptors are critical for body movement and serve as major pharmacological targets for several classes of anthelmintic drugs. It is preferentially activated by bephenium.
Activation of the receptor leads to ion channel opening, depolarization, and muscle contraction. Anthelmintics act as agonists or antagonists, disrupting normal neuromuscular function and causing paralysis or death of the nematode.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acetylcholine Receptor, Nematode Type B (None).